New Zealand markets open in 46 minutes

AbbVie Inc. (ABBV)

NYSE - Nasdaq Real-time price. Currency in USD
Add to watchlist
164.94+1.22 (+0.75%)
As of 03:13PM EST. Market open.
Currency in USD

Valuation measures4

Market cap (intra-day) 289.43B
Enterprise value 347.16B
Trailing P/E 21.82
Forward P/E 14.29
PEG ratio (5-yr expected) N/A
Price/sales (ttm)5.03
Price/book (mrq)18.10
Enterprise value/revenue 6.00
Enterprise value/EBITDA 13.71

Trading information

Stock price history

Beta (5Y monthly) 0.67
52-week change 334.34%
S&P500 52-week change 3-16.16%
52-week high 3175.91
52-week low 3120.75
50-day moving average 3149.00
200-day moving average 3149.27

Share statistics

Avg vol (3-month) 35.67M
Avg vol (10-day) 35.06M
Shares outstanding 51.77B
Implied shares outstanding 6N/A
Float 81.77B
% held by insiders 10.11%
% held by institutions 170.81%
Shares short (14 Nov 2022) 412.91M
Short ratio (14 Nov 2022) 42.35
Short % of float (14 Nov 2022) 40.73%
Short % of shares outstanding (14 Nov 2022) 40.73%
Shares short (prior month 13 Oct 2022) 414M

Dividends & splits

Forward annual dividend rate 45.92
Forward annual dividend yield 43.62%
Trailing annual dividend rate 35.64
Trailing annual dividend yield 33.44%
5-year average dividend yield 44.35
Payout ratio 473.73%
Dividend date 314 Feb 2023
Ex-dividend date 411 Jan 2023
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends 30 Dec 2021
Most-recent quarter (mrq)29 Sept 2022

Profitability

Profit margin 23.19%
Operating margin (ttm)36.51%

Management effectiveness

Return on assets (ttm)9.09%
Return on equity (ttm)90.65%

Income statement

Revenue (ttm)57.82B
Revenue per share (ttm)32.64
Quarterly revenue growth (yoy)3.30%
Gross profit (ttm)38.88B
EBITDA 29.4B
Net income avi to common (ttm)13.34B
Diluted EPS (ttm)7.50
Quarterly earnings growth (yoy)24.20%

Balance sheet

Total cash (mrq)11.88B
Total cash per share (mrq)6.72
Total debt (mrq)70B
Total debt/equity (mrq)436.76
Current ratio (mrq)0.93
Book value per share (mrq)9.04

Cash flow statement

Operating cash flow (ttm)22.59B
Levered free cash flow (ttm)19.95B